ScienceDex / Researcher record
Stacy Remiszewski
- Evrys Bio, LLC (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
Not you? Find your own page- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,945,679 | 2 | #5,627 |
| 2025 | $1,940,568 | 2 | #7,069 |
| 2026 | $961,797 | 1 | #20,202 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected2 records
- FY20252 records
- FY20261 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12324861Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2024 award records by amount
NIH award records listing Stacy Remiszewski as a PI. Multi-PI records show the full award amount for context.
- 5R44AI114079-06R44Contact PIA single antiviral to treat multiple opportunistic infections$983.9Kaward amount
- 4R44AI157725-02R44Contact PIDevelopment of a host-targeted antiviral as a chronic hepatitis B therapeutic with potential to achieve a functional cure$961.8Kaward amount
Award organization
Organizations that administered FY2024 awards listing Stacy Remiszewski as a PI.
FY2024 award administered by Evrys Bio, LLC (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardEvrys Bio, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5627
- 2025$2M Cumulative Funding